NorthStar Asset Management (Pennsylvania)’s NovoCure NVCR Stock Holding History

NorthStar Asset Management (Pennsylvania)’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-11,665	Closed	-$967K	–	141
2022 Q1	$967K	Sell	11,665 -3,925	-25%	-$289K	0.25%	71
2021 Q4	$1.17M	Sell	15,590 -590	-4%	-$59.2K	0.28%	70
2021 Q3	$1.88M	Hold	16,180	–	–	0.49%	48
2021 Q2	$3.59M	Buy	16,180 +110	+0.7%	+$21.4K	0.94%	25
2021 Q1	$2.12M	Sell	16,070 -825	-5%	-$131K	0.6%	39
2020 Q4	$2.92M	Sell	16,895 -210	-1%	-$28.7K	0.83%	27
2020 Q3	$1.9M	Buy	17,105 +75	+0.4%	+$6K	0.61%	38
2020 Q2	$1.01M	Buy	+17,030	New	+$1.12M	0.36%	56

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NorthStar Asset Management (Pennsylvania)'s NVCR Position: Q2 2022 in Review

NorthStar Asset Management (Pennsylvania) sold out of NovoCure (NVCR) in Q2 2022, closing a stake of 11,665 shares — an estimated $967K sold.

NorthStar Asset Management (Pennsylvania) first reported a position in NVCR in Q2 2020 and held it in 8 quarters. The position peaked at $3.59M in Q2 2021. 317 funds tracked by Wall St. Rank hold NVCR as of Q2 2022.

NorthStar Asset Management (Pennsylvania) reported no remaining NovoCure position as of Q2 2022 after selling out during the quarter.
NorthStar Asset Management (Pennsylvania) sold 11,665 NovoCure shares in Q2 2022, an estimated $967K.
NorthStar Asset Management (Pennsylvania) first reported a position in NovoCure in Q2 2020 and held it in 8 quarters.
NorthStar Asset Management (Pennsylvania)'s NovoCure position peaked at $3.59M in Q2 2021.
317 funds tracked by Wall St. Rank held NovoCure as of Q2 2022.

Based on NorthStar Asset Management (Pennsylvania)'s 13F filing for Q2 2022, filed 20 Jul 2022.